Composition : Paclitaxel IP 6mg + Polyoxyl 35 Castor oil IP 527mg + Dehydrtes Alcohol IP 49.7% v/v Injection
Dosage Form : Injection
Packaging Type : Vial
Packaging : 300mg
Price : ₹0/-
Please Contact For Best Price
Packlin 300 injection is a high-potency, intravenous chemotherapy solution containing Paclitaxel 6 mg/mL, an essential drug in the Taxane class. It is a mainstay of chemotherapy regimens worldwide for treating some of the most prevalent and aggressive cancers.
Mechanism and Impact:Paclitaxel is a cytotoxic agent that promotes the assembly of microtubules from tubulin dimers and stabilizes them, inhibiting their normal depolymerization. This action prevents the necessary restructuring of the microtubule network required for cell division, thereby leading to the arrest of mitosis and the eventual death of rapidly dividing cancer cells.
Key Therapeutic Uses:
-
Breast Cancer: Used in adjuvant, neoadjuvant, and metastatic settings.
-
Ovarian Cancer: Standard treatment for advanced ovarian carcinoma.
-
Non-Small Cell Lung Cancer (NSCLC): Used in combination regimens.
-
Kaposi's Sarcoma: For advanced cases unresponsive to prior therapy.
We offer an exclusive PCD Pharma Franchise opportunity for Packlin 300 injection, enabling partners to secure a dominant position in the highly reliable injectable oncology market.
Read More